4
Changes in Ownership
Citius Pharmaceuticals, Inc. Filed Acc 0001477932-16-011029
Options or other derivatives
- Director acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kane William Director | 2016-06-23 | Grant or award · Options to Purchase Common Stock | +200,000 | $0.80 | $160,000 | 200,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…